Carolinas Wealth Consulting’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-41,356
| Closed | -$91K | – | 414 |
|
2025
Q1 | $91K | Hold |
41,356
| – | – | 0.02% | 256 |
|
2024
Q4 | $63.3K | Buy |
41,356
+13,669
| +49% | +$20.9K | 0.01% | 325 |
|
2024
Q3 | $55.1K | Buy |
27,687
+5,857
| +27% | +$11.7K | 0.01% | 348 |
|
2024
Q2 | $76.4K | Buy |
21,830
+2,130
| +11% | +$7.46K | 0.01% | 302 |
|
2024
Q1 | $54.6K | Buy |
+19,700
| New | +$54.6K | 0.01% | 359 |
|